Concepts (243)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Saccharomyces cerevisiae | 12 | 2022 | 434 | 3.460 |
Why?
|
Saccharomyces cerevisiae Proteins | 10 | 2022 | 276 | 2.550 |
Why?
|
Protein Biosynthesis | 10 | 2015 | 378 | 2.250 |
Why?
|
Heat-Shock Response | 4 | 2022 | 47 | 2.210 |
Why?
|
Evolution, Molecular | 12 | 2013 | 813 | 1.720 |
Why?
|
Heat-Shock Proteins | 4 | 2022 | 179 | 1.650 |
Why?
|
Poly(A)-Binding Proteins | 2 | 2022 | 9 | 1.450 |
Why?
|
Kidney Calculi | 7 | 2015 | 339 | 1.380 |
Why?
|
Protein Folding | 8 | 2022 | 282 | 1.060 |
Why?
|
Proteins | 8 | 2010 | 777 | 1.040 |
Why?
|
Cytoplasmic Granules | 3 | 2021 | 94 | 0.920 |
Why?
|
Gene Expression | 4 | 2015 | 1284 | 0.860 |
Why?
|
Selection, Genetic | 7 | 2014 | 502 | 0.860 |
Why?
|
DNA-Binding Proteins | 2 | 2020 | 1208 | 0.860 |
Why?
|
HSP40 Heat-Shock Proteins | 1 | 2022 | 18 | 0.840 |
Why?
|
HSP70 Heat-Shock Proteins | 2 | 2022 | 113 | 0.840 |
Why?
|
Fungal Proteins | 2 | 2013 | 141 | 0.810 |
Why?
|
Models, Genetic | 6 | 2015 | 926 | 0.800 |
Why?
|
Transcription Factors | 3 | 2020 | 1565 | 0.790 |
Why?
|
Calcium Phosphates | 3 | 2015 | 77 | 0.730 |
Why?
|
Calcium Oxalate | 4 | 2015 | 185 | 0.730 |
Why?
|
Ribosomes | 3 | 2015 | 111 | 0.700 |
Why?
|
Hypercalciuria | 3 | 2015 | 47 | 0.700 |
Why?
|
Phase Transition | 1 | 2019 | 17 | 0.690 |
Why?
|
Codon | 3 | 2014 | 124 | 0.680 |
Why?
|
Organelles | 1 | 2019 | 52 | 0.670 |
Why?
|
Saccharomycetales | 2 | 2013 | 11 | 0.590 |
Why?
|
Cytosol | 2 | 2020 | 189 | 0.560 |
Why?
|
Open Reading Frames | 2 | 2014 | 117 | 0.520 |
Why?
|
RNA Stability | 1 | 2015 | 86 | 0.510 |
Why?
|
Nucleoside Q | 1 | 2014 | 8 | 0.510 |
Why?
|
Genome, Insect | 1 | 2014 | 75 | 0.490 |
Why?
|
Genetic Fitness | 2 | 2013 | 37 | 0.490 |
Why?
|
Kidney Tubules, Proximal | 2 | 2015 | 61 | 0.480 |
Why?
|
Kidney Tubules | 2 | 2015 | 94 | 0.470 |
Why?
|
RNA, Transfer | 1 | 2014 | 151 | 0.450 |
Why?
|
Calcium | 4 | 2015 | 1156 | 0.440 |
Why?
|
Amino Acid Substitution | 4 | 2009 | 339 | 0.410 |
Why?
|
Drosophila | 1 | 2014 | 498 | 0.380 |
Why?
|
Transcriptome | 2 | 2018 | 580 | 0.370 |
Why?
|
Hydrogen-Ion Concentration | 3 | 2020 | 493 | 0.370 |
Why?
|
Biophysical Phenomena | 1 | 2010 | 120 | 0.370 |
Why?
|
Genome | 2 | 2010 | 372 | 0.360 |
Why?
|
Mutation | 5 | 2013 | 3968 | 0.350 |
Why?
|
Protein Aggregates | 2 | 2022 | 20 | 0.350 |
Why?
|
Stress, Physiological | 2 | 2021 | 227 | 0.310 |
Why?
|
X-Ray Microtomography | 2 | 2014 | 80 | 0.300 |
Why?
|
Recombination, Genetic | 2 | 2007 | 439 | 0.290 |
Why?
|
Mutagenesis | 3 | 2017 | 199 | 0.270 |
Why?
|
Parathyroid Hormone | 2 | 2015 | 218 | 0.270 |
Why?
|
Nephrocalcinosis | 1 | 2015 | 9 | 0.270 |
Why?
|
beta-Lactamases | 2 | 2005 | 52 | 0.270 |
Why?
|
Renal Reabsorption | 1 | 2015 | 8 | 0.260 |
Why?
|
Nephrostomy, Percutaneous | 1 | 2015 | 31 | 0.260 |
Why?
|
Kidney Tubules, Distal | 1 | 2015 | 20 | 0.260 |
Why?
|
Medullary Sponge Kidney | 1 | 2015 | 6 | 0.260 |
Why?
|
Renal Elimination | 1 | 2015 | 8 | 0.260 |
Why?
|
Gene Library | 1 | 2005 | 130 | 0.260 |
Why?
|
Lithotripsy | 1 | 2015 | 41 | 0.260 |
Why?
|
Nephrolithiasis | 1 | 2015 | 22 | 0.260 |
Why?
|
Point Mutation | 1 | 2005 | 246 | 0.250 |
Why?
|
Hyperparathyroidism, Secondary | 1 | 2015 | 70 | 0.250 |
Why?
|
Kidney Medulla | 1 | 2014 | 80 | 0.240 |
Why?
|
Durapatite | 1 | 2014 | 28 | 0.240 |
Why?
|
Hyperoxaluria, Primary | 1 | 2013 | 4 | 0.240 |
Why?
|
Vitamin D Deficiency | 1 | 2015 | 103 | 0.240 |
Why?
|
Oxalates | 1 | 2013 | 48 | 0.230 |
Why?
|
Hot Temperature | 2 | 2017 | 206 | 0.230 |
Why?
|
Thiazides | 1 | 2013 | 19 | 0.230 |
Why?
|
Molecular Chaperones | 2 | 2016 | 111 | 0.230 |
Why?
|
Parathyroid Glands | 1 | 2013 | 74 | 0.230 |
Why?
|
Chlorthalidone | 1 | 2013 | 25 | 0.230 |
Why?
|
Osteogenesis | 1 | 2015 | 242 | 0.230 |
Why?
|
Proteomics | 3 | 2018 | 212 | 0.230 |
Why?
|
Transcription, Genetic | 5 | 2015 | 1135 | 0.220 |
Why?
|
Diuretics | 1 | 2013 | 124 | 0.220 |
Why?
|
Vitamin D | 1 | 2015 | 261 | 0.220 |
Why?
|
Binding, Competitive | 1 | 2022 | 145 | 0.210 |
Why?
|
Pyruvate Kinase | 1 | 2021 | 13 | 0.210 |
Why?
|
Amyloid | 1 | 2021 | 85 | 0.200 |
Why?
|
Escherichia coli | 2 | 2018 | 597 | 0.200 |
Why?
|
Renal Insufficiency, Chronic | 1 | 2015 | 350 | 0.180 |
Why?
|
Cyanobacteria | 1 | 2020 | 111 | 0.180 |
Why?
|
Sequence Alignment | 3 | 2017 | 351 | 0.180 |
Why?
|
Cell Compartmentation | 1 | 2019 | 69 | 0.170 |
Why?
|
Cell Cycle Proteins | 1 | 2021 | 388 | 0.170 |
Why?
|
Rhodopseudomonas | 1 | 2018 | 51 | 0.170 |
Why?
|
Drosophila melanogaster | 3 | 2014 | 599 | 0.160 |
Why?
|
Cytoplasm | 1 | 2019 | 281 | 0.160 |
Why?
|
Nitrogen | 1 | 2018 | 70 | 0.160 |
Why?
|
Protein Binding | 1 | 2022 | 1456 | 0.160 |
Why?
|
RNA, Messenger | 3 | 2015 | 1981 | 0.160 |
Why?
|
Symbiosis | 1 | 2018 | 118 | 0.150 |
Why?
|
Intrinsically Disordered Proteins | 1 | 2017 | 10 | 0.150 |
Why?
|
Proline | 1 | 2017 | 57 | 0.150 |
Why?
|
Liposomes | 2 | 2015 | 91 | 0.150 |
Why?
|
Hydrophobic and Hydrophilic Interactions | 1 | 2017 | 93 | 0.150 |
Why?
|
Ribonucleases | 1 | 2017 | 92 | 0.150 |
Why?
|
Protein Domains | 1 | 2017 | 128 | 0.140 |
Why?
|
Humans | 17 | 2016 | 86643 | 0.140 |
Why?
|
Amino Acid Sequence | 3 | 2017 | 2062 | 0.140 |
Why?
|
Protein Synthesis Inhibitors | 1 | 2015 | 36 | 0.140 |
Why?
|
Cycloheximide | 1 | 2015 | 56 | 0.140 |
Why?
|
Bacterial Proteins | 2 | 2012 | 864 | 0.130 |
Why?
|
Phylogeny | 2 | 2014 | 1137 | 0.130 |
Why?
|
Animals | 7 | 2015 | 26582 | 0.130 |
Why?
|
Gene Expression Regulation, Fungal | 1 | 2015 | 61 | 0.130 |
Why?
|
Anticodon | 1 | 2014 | 18 | 0.130 |
Why?
|
Sarcoma, Ewing | 1 | 2015 | 42 | 0.130 |
Why?
|
Tomography, X-Ray Computed | 1 | 2015 | 2601 | 0.130 |
Why?
|
Sucrose | 1 | 2015 | 64 | 0.130 |
Why?
|
Postprandial Period | 2 | 2015 | 47 | 0.120 |
Why?
|
Camptothecin | 1 | 2015 | 189 | 0.120 |
Why?
|
RNA Processing, Post-Transcriptional | 1 | 2015 | 105 | 0.120 |
Why?
|
Fasting | 2 | 2015 | 161 | 0.120 |
Why?
|
Molecular Sequence Data | 3 | 2014 | 3030 | 0.120 |
Why?
|
Methylobacterium extorquens | 1 | 2012 | 1 | 0.110 |
Why?
|
Carbon-Nitrogen Ligases | 1 | 2012 | 4 | 0.110 |
Why?
|
Likelihood Functions | 1 | 2013 | 251 | 0.110 |
Why?
|
Kinetics | 1 | 2014 | 1513 | 0.100 |
Why?
|
Middle Aged | 6 | 2015 | 25028 | 0.100 |
Why?
|
Protein Denaturation | 1 | 2010 | 106 | 0.100 |
Why?
|
Base Sequence | 1 | 2014 | 2330 | 0.100 |
Why?
|
Adult | 6 | 2015 | 25648 | 0.090 |
Why?
|
Biopsy | 2 | 2015 | 1163 | 0.090 |
Why?
|
Luminescent Proteins | 1 | 2010 | 144 | 0.090 |
Why?
|
Nuclear Proteins | 1 | 2015 | 696 | 0.090 |
Why?
|
Female | 8 | 2015 | 44532 | 0.090 |
Why?
|
Mutagenesis, Site-Directed | 2 | 2012 | 279 | 0.090 |
Why?
|
Chaperonins | 1 | 2009 | 10 | 0.090 |
Why?
|
Genetic Code | 1 | 2009 | 25 | 0.090 |
Why?
|
Male | 7 | 2015 | 40965 | 0.090 |
Why?
|
Sequence Analysis, Protein | 2 | 2008 | 28 | 0.090 |
Why?
|
Protein Stability | 1 | 2009 | 99 | 0.090 |
Why?
|
Nerve Tissue | 1 | 2008 | 8 | 0.080 |
Why?
|
Models, Biological | 2 | 2015 | 1749 | 0.080 |
Why?
|
Aged | 4 | 2015 | 18415 | 0.080 |
Why?
|
Probability | 2 | 2005 | 355 | 0.080 |
Why?
|
Cytochrome P-450 Enzyme System | 1 | 2007 | 79 | 0.080 |
Why?
|
Antibody Affinity | 1 | 2007 | 38 | 0.080 |
Why?
|
Computer Simulation | 2 | 2008 | 1078 | 0.070 |
Why?
|
Caenorhabditis elegans | 1 | 2008 | 223 | 0.070 |
Why?
|
Temperature | 1 | 2007 | 396 | 0.070 |
Why?
|
Time Factors | 2 | 2015 | 5210 | 0.070 |
Why?
|
Genes, Duplicate | 1 | 2005 | 19 | 0.070 |
Why?
|
Nanoparticles | 1 | 2007 | 157 | 0.070 |
Why?
|
Poisson Distribution | 1 | 2005 | 51 | 0.070 |
Why?
|
Fluorescence | 1 | 2005 | 102 | 0.070 |
Why?
|
Peptide Fragments | 1 | 2007 | 460 | 0.070 |
Why?
|
Recombinant Proteins | 1 | 2007 | 1014 | 0.070 |
Why?
|
Protein Conformation | 3 | 2020 | 881 | 0.070 |
Why?
|
Protein Structure, Secondary | 1 | 2006 | 330 | 0.070 |
Why?
|
Ammonium Chloride | 1 | 2015 | 22 | 0.070 |
Why?
|
Least-Squares Analysis | 1 | 2015 | 48 | 0.070 |
Why?
|
Bicarbonates | 1 | 2015 | 60 | 0.060 |
Why?
|
Antibodies | 1 | 2007 | 350 | 0.060 |
Why?
|
Sus scrofa | 1 | 2015 | 45 | 0.060 |
Why?
|
Water-Electrolyte Balance | 1 | 2015 | 66 | 0.060 |
Why?
|
Phosphorus | 1 | 2015 | 118 | 0.060 |
Why?
|
Nonlinear Dynamics | 1 | 2015 | 73 | 0.060 |
Why?
|
Models, Chemical | 1 | 2005 | 178 | 0.060 |
Why?
|
Magnesium | 1 | 2015 | 177 | 0.060 |
Why?
|
Structure-Activity Relationship | 1 | 2005 | 408 | 0.060 |
Why?
|
Amino Acids | 1 | 2005 | 252 | 0.060 |
Why?
|
Urodynamics | 1 | 2015 | 122 | 0.060 |
Why?
|
Risk Factors | 2 | 2015 | 5417 | 0.060 |
Why?
|
Genes | 1 | 2005 | 305 | 0.060 |
Why?
|
Databases, Genetic | 1 | 2005 | 260 | 0.060 |
Why?
|
Dietary Supplements | 1 | 2015 | 128 | 0.060 |
Why?
|
Gene Expression Regulation, Bacterial | 2 | 2018 | 204 | 0.060 |
Why?
|
ErbB Receptors | 1 | 2007 | 485 | 0.060 |
Why?
|
Sodium | 1 | 2015 | 341 | 0.060 |
Why?
|
Thermodynamics | 1 | 2005 | 309 | 0.060 |
Why?
|
Microscopy, Electron, Transmission | 1 | 2014 | 134 | 0.060 |
Why?
|
Linear Models | 1 | 2015 | 421 | 0.060 |
Why?
|
Hyperoxaluria | 1 | 2013 | 26 | 0.060 |
Why?
|
Data Interpretation, Statistical | 1 | 2005 | 297 | 0.060 |
Why?
|
Decision Support Techniques | 1 | 2015 | 160 | 0.060 |
Why?
|
Antineoplastic Agents | 1 | 2015 | 2360 | 0.060 |
Why?
|
Glomerular Filtration Rate | 1 | 2015 | 384 | 0.060 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2005 | 689 | 0.060 |
Why?
|
Polymerase Chain Reaction | 1 | 2005 | 927 | 0.060 |
Why?
|
Calcinosis | 1 | 2014 | 224 | 0.060 |
Why?
|
Genetics, Population | 1 | 2006 | 394 | 0.060 |
Why?
|
Renal Insufficiency | 1 | 2013 | 114 | 0.060 |
Why?
|
Escherichia coli Proteins | 2 | 2018 | 179 | 0.050 |
Why?
|
Young Adult | 2 | 2015 | 5976 | 0.050 |
Why?
|
Computational Biology | 1 | 2005 | 528 | 0.050 |
Why?
|
Fructosediphosphates | 1 | 2021 | 2 | 0.050 |
Why?
|
Sex Factors | 1 | 2015 | 1054 | 0.050 |
Why?
|
Adolescent | 2 | 2014 | 8981 | 0.050 |
Why?
|
Case-Control Studies | 1 | 2015 | 1805 | 0.050 |
Why?
|
Kidney Diseases | 1 | 2014 | 418 | 0.050 |
Why?
|
Adenosine Triphosphate | 1 | 2021 | 314 | 0.050 |
Why?
|
Cross-Sectional Studies | 1 | 2015 | 1621 | 0.040 |
Why?
|
Blood Pressure | 1 | 2015 | 1143 | 0.040 |
Why?
|
Mice | 2 | 2015 | 11352 | 0.040 |
Why?
|
PII Nitrogen Regulatory Proteins | 1 | 2018 | 1 | 0.040 |
Why?
|
Ammonium Compounds | 1 | 2018 | 8 | 0.040 |
Why?
|
Fermentation | 1 | 2018 | 13 | 0.040 |
Why?
|
Biomarkers | 1 | 2015 | 1718 | 0.040 |
Why?
|
Culture Media | 1 | 2018 | 147 | 0.040 |
Why?
|
Coculture Techniques | 1 | 2018 | 164 | 0.040 |
Why?
|
Insulin | 1 | 2013 | 1160 | 0.040 |
Why?
|
Cation Transport Proteins | 1 | 2018 | 64 | 0.040 |
Why?
|
Carbon | 1 | 2018 | 80 | 0.040 |
Why?
|
Practice Guidelines as Topic | 1 | 2015 | 1036 | 0.040 |
Why?
|
Prognosis | 1 | 2015 | 3679 | 0.040 |
Why?
|
Infant | 1 | 2013 | 3046 | 0.040 |
Why?
|
Sequence Analysis, RNA | 1 | 2018 | 217 | 0.040 |
Why?
|
Algorithms | 1 | 2015 | 1830 | 0.040 |
Why?
|
Child, Preschool | 1 | 2013 | 3612 | 0.040 |
Why?
|
Protein Structure, Tertiary | 2 | 2008 | 736 | 0.030 |
Why?
|
Regression Analysis | 2 | 2008 | 596 | 0.030 |
Why?
|
Cell Line, Tumor | 2 | 2015 | 2426 | 0.030 |
Why?
|
Tissue Distribution | 1 | 2015 | 290 | 0.030 |
Why?
|
Drug Combinations | 1 | 2015 | 224 | 0.030 |
Why?
|
Tumor Burden | 1 | 2015 | 289 | 0.030 |
Why?
|
Xenograft Model Antitumor Assays | 1 | 2015 | 458 | 0.030 |
Why?
|
United States | 1 | 2015 | 6672 | 0.030 |
Why?
|
Neoplasms | 1 | 2007 | 2898 | 0.030 |
Why?
|
Macrophages | 1 | 2015 | 554 | 0.030 |
Why?
|
Gene Expression Regulation, Enzymologic | 1 | 2012 | 214 | 0.030 |
Why?
|
Models, Molecular | 2 | 2005 | 1286 | 0.020 |
Why?
|
Reproducibility of Results | 1 | 2015 | 2705 | 0.020 |
Why?
|
Disease Models, Animal | 1 | 2015 | 2232 | 0.020 |
Why?
|
Enzyme Stability | 1 | 2007 | 39 | 0.020 |
Why?
|
Biotransformation | 1 | 2007 | 50 | 0.020 |
Why?
|
Heme | 1 | 2007 | 63 | 0.020 |
Why?
|
Principal Component Analysis | 1 | 2008 | 155 | 0.020 |
Why?
|
Topotecan | 1 | 2007 | 45 | 0.020 |
Why?
|
Epidermal Growth Factor | 1 | 2007 | 119 | 0.020 |
Why?
|
Solubility | 1 | 2007 | 177 | 0.020 |
Why?
|
Substrate Specificity | 1 | 2007 | 347 | 0.020 |
Why?
|
Crystallography, X-Ray | 1 | 2008 | 485 | 0.020 |
Why?
|
Pharmaceutical Preparations | 1 | 2007 | 92 | 0.020 |
Why?
|
Statistics, Nonparametric | 1 | 2006 | 307 | 0.020 |
Why?
|
Static Electricity | 1 | 2005 | 89 | 0.020 |
Why?
|
Cell Survival | 1 | 2007 | 969 | 0.020 |
Why?
|
Analysis of Variance | 1 | 2006 | 912 | 0.020 |
Why?
|
Drosophila Proteins | 1 | 2008 | 488 | 0.010 |
Why?
|
Models, Theoretical | 1 | 2005 | 482 | 0.010 |
Why?
|
Gene Expression Regulation | 1 | 2007 | 1920 | 0.010 |
Why?
|